Zurueck zur Suche

Reporte zur Charge U029145

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

10Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 4 MO 2 MD 1 MN 1 IN 1 IL 1

VAERS 2475161

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U029145

mild
Staat
MO
Alter
1,0
Geschlecht
M
Eingang
11.10.2022
Impfdatum
29.08.2022
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Hypotonia Pyrexia Staring Unresponsive to stimuli

Symptomtext

8/29/22-fever started @ night 102 8/30/22 1245pm pt was in moms arms starting up at ceiling, unresponsive to get his attn. Body was limp. Lasted over a minute. EMS called, pt was better when EMS arrived. Patient checked out. Parents drove child to ER for evaluation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NONE NOTED
Vorgeschichte
Right Aortic Arch
Andere Medikamente
hydrocortizone 1% ointment
Allergien
Amoxicillan
Vorherige Impfungen
-

VAERS 2418202

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U029145

mild
Staat
MD
Alter
0,2
Geschlecht
M
Eingang
23.08.2022
Impfdatum
05.08.2022
Beginn
05.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Diarrhoea Irritability Occult blood negative Rotavirus test positive Stool analysis abnormal Vomiting

Symptomtext

-Pt given Rotarix on 8/5/22 -Pt seen again on 8/8/22 for irritability, vomiting & diarrhea -Seen 8/16/22 for persisting symptoms

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
Hemoccult stool - neg GI stool panel - Rotavirus
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKA
Vorherige Impfungen
-

VAERS 2460027

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U029145

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
26.09.2022
Impfdatum
30.08.2022
Beginn
30.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no adverse event; an improperly stored dose of PEDVAXHIB was administered to the patient on 30AUG2022; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. No information about the patient's pertinent medical history, concurrent conditions, concomitant medications, or drug reactions or allergies was provided. On 30-AUG-2022, the patient was vaccinated with haemophilus B conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) dose 0.5 milliliter, lot #U029145, expiration date: 30-MAR-2024, administered for prophylaxis (strength, route of administration, vaccination scheme frequency, and anatomical location were not reported) after a temperature excursion (temperature: 35.7 Fahrenheit (F); time frame: 4 hours and 26 minutes) (product storage error). There was no previous temperature excursion. No additional adverse event was reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2429188

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U029145

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
06.09.2022
Impfdatum
12.08.2022
Beginn
12.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AE reported; An improperly stored dose of PEDVAXHIB was administered to the patient on 12AUG2022; This spontaneous report has been received from a nurse concerning a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, and historical drugs were not reported. Concomitant therapies included a dose of rotavirus vaccine live oral 1v (ROTARIX). On 12-AUG-2022, the patient was vaccinated with improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) 0.5 ml (lot number U029145 has been verified to be a valid lot number for haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB), expiration date reported and confirmed as 30-MAR-2024) as prophylaxis (route of administration and anatomical location were not provided). The vaccine administered suffered a temperature excursion of 35.7 Fahrenheit degrees (F) for a time frame of 4 hours and 26 minutes (Product storage error). This vaccine had not suffered previous temperature excursions. No additional information provided. No additional adverse events (AE) reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2426112

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U029145

gering
Staat
MI
Alter
0,4
Geschlecht
U
Eingang
01.09.2022
Impfdatum
12.08.2022
Beginn
12.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration No adverse event Product preparation error

Symptomtext

The patient has had no adverse side effects at this time.; Medical Assistant called stating that a dose of PEDVAX HIB was drawn out of the vial into a plastic syringe and accidentally reconstituted with ROTARIX instead of the recommended ROTARIX diluent.; Given to a 5 month old patient orally instead of intramuscularly today.; This spontaneous report was received from a medical assistant regarding a 5-month-old patient of an unknown gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 12-AUG-2022, the patient was accidentally vaccinated with a dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) 0.5 milliliter x 1 dose, lot #U029145, expiration date: 30-MAR-2024, (strength was not provided) as prophylaxis, which was used as diluent of rotavirus vaccine live oral 1v (ROTARIX), 1 milliliter x dose, expiration date: 29-JUN-2023 (strength, formulation, lot #, and indication were not provided), instead of the recommended diluent (Product preparation error) and it was given to the patient orally instead of intramuscularly (Incorrect route of product administration). At the time of reporting, the patient had no adverse side effects. The reporter stated that they were able to get in touch with poison control who stated there should be no issues or adverse side effects with haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) taken orally an they could vaccinate the patient via the appropriate route.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2419961

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U029145

gering
Staat
MN
Alter
-
Geschlecht
M
Eingang
25.08.2022
Impfdatum
16.08.2022
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Wrong product administered

Symptomtext

Clinical staff gave the wrong vaccine. Patient had not reaction to the vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
No Allergies
Vorherige Impfungen
-

VAERS 2408321

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U029145

gering
Staat
IN
Alter
1,8
Geschlecht
F
Eingang
11.08.2022
Impfdatum
10.08.2022
Beginn
10.08.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event

Symptomtext

Patient received two doses of Pedvax Hib on 08/10/22 and it should have only been one dose. The patient had no adverse reactions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
none
Allergien
Amoxicillin
Vorherige Impfungen
-

VAERS 2379303

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U029145

gering
Staat
MI
Alter
0,3
Geschlecht
F
Eingang
22.07.2022
Impfdatum
19.07.2022
Beginn
22.07.2022
Tage bis Beginn
3,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

DTAP-IPV administered to patient under the age of 4. No Sx or Tx currently needed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
Nystatin 100,000 unit/gram topical cream
Allergien
N/A
Vorherige Impfungen
-

VAERS 2361210

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U029145

gering
Staat
IL
Alter
1,3
Geschlecht
F
Eingang
07.07.2022
Impfdatum
07.07.2022
Beginn
07.07.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Eye swelling Ocular hyperaemia

Symptomtext

Mom reports Left eye swelling and redness after receiving vaccination at 0900. Mom then called office at 1530 to report that eye swelling has improved, however is still reddened. No medications such as Benadryl have been given since receiving immunization.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Eye swelling
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2314894

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U029145

gering
Staat
MO
Alter
0,3
Geschlecht
M
Eingang
10.06.2022
Impfdatum
31.05.2022
Beginn
31.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; Nurse reported two temperature excursions on multiple refrigerated vaccines. There was a prior excursion on 5/3/2022 and a recent excursion on 5/26/2022. She said it was very likely all vaccines had been administered since the excursions occurred.; This spontaneous report has been received from a nurse, concerning a 03-months-old male patient. No information was provided regarding the patient's pertinent medical history, concomitant medications, concurrent conditions, and previous drug reactions or allergies. On 03-MAY-2022, the rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot # U026664, and Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) lot# U029145 experienced a temperature excursion of 47.3 Fahrenheit degrees (F) for 5 minutes; additionally on 26-MAY-2022 experienced an additional temperature excursion of 35.2 F for 56 seconds. If a digital data logger was involved was not reported (product storage error). Consequently, on 31-MAY-2022, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot number reported as U026664 confirmed as valid, expiration date reported and stablished as 24-FEB-2023) administered orally (formulation, strength, dose, vaccination scheme were not provided) and with Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB (lot number reported as U029145 confirmed as valid, expiration date reported and stablished as 30-MAR-2024) (formulation, strength, dose, vaccination scheme, route of administration and anatomical location, lot number and expiration date were not provided), both administered as prophylaxis (product storage error). No additional adverse events (AE) reported (no adverse event). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2206USA001103:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-